Seattle Genetics Inc. (SGEN) Tops Q1 EPS by 1c
Get Alerts SGEN Hot Sheet
Price: $228.74 --0%
Revenue Growth %: -100.0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
FSI, RELV, NEOM, More
Revenue Growth %: -100.0%
Financial Fact:
Revenue from collaboration and license agreements: 23.97M
Today's EPS Names:
FSI, RELV, NEOM, More
Join SI Premium – FREE
Seattle Genetics Inc. (NASDAQ: SGEN) reported Q1 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $52.33 million.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
For earnings history and earnings-related data on Seattle Genetics Inc. (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 2 reasons why Tesla stock fell on Thursday
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
- Oxford Industries (OXM) Reports In-Line Q4 EPS, provides guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!